UBS Group’s NeOnc Technologies NTHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.84K Buy
1,731
+1,458
+534% +$7.29K ﹤0.01% 8730
2026
Q1
$1.91K Sell
273
-2,227
-89% -$20.2K ﹤0.01% 9406
2025
Q4
$20.7K Sell
2,500
-613
-20% -$5.75K ﹤0.01% 7755
2025
Q3
$28.3K Sell
3,113
-6,331
-67% -$42.4K ﹤0.01% 7935
2025
Q2
$33.7K Buy
+9,444
New +$63.7K ﹤0.01% 8081

Other funds holding NTHI

UBS Group's NTHI Position: Q2 2026 in Review

UBS Group increased its NeOnc Technologies (NTHI) stake by 534% in Q2 2026, buying an estimated $7.29K and bringing the position to 1,731 shares worth $7.84K. The position accounts for ﹤0.01% of the portfolio, ranked #8730.

UBS Group first reported a position in NTHI in Q2 2025 and has held it in 5 quarters since. The position peaked at $33.7K in Q2 2025. 21 funds tracked by Wall St. Rank hold NTHI as of Q2 2026.

  • UBS Group held 1,731 shares of NeOnc Technologies worth $7.84K as of Q2 2026.
  • UBS Group bought 1,458 NeOnc Technologies shares in Q2 2026, an estimated $7.29K.
  • NeOnc Technologies made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #8730 holding.
  • UBS Group first reported a position in NeOnc Technologies in Q2 2025 and has held it in 5 quarters since.
  • UBS Group's NeOnc Technologies position peaked at $33.7K in Q2 2025.
  • 21 funds tracked by Wall St. Rank held NeOnc Technologies as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.